LOGO
LOGO

Article Search

Discover the power of RTTNews website's advanced search page, designed for seamless Article retrieval by Company Name, Stock Symbol, and other criteria.
Stay updated with the Latest News on specific Companies, Financial Insights, and Market Trends. We Ensure you to get the most relevant information instantly.

Symbol  
Company  
Currency Symbol   eg (EUR/USD)
Keyword  
  • RBC Capital Markets Is Lowering Regeneron Pharmaceuticals (REGN) 2013 Estimate To -1.73 From -1.68 11/21/2011 11:28:19 AM
  • Robert W. Baird Reiterates Regeneron Pharmaceuticals (REGN) At Neutral With $56 Price Target 11/1/2011 8:58:38 AM
  • Robert W. Baird Is Raising Regeneron Pharmaceuticals (REGN) FY12 Estimate To -1.48 From -1.61 11/1/2011 8:58:17 AM
  • Robert W. Baird Is Raising Regeneron Pharmaceuticals (REGN) FY11 Estimate To -2.55 From -2.73 11/1/2011 8:57:55 AM
  • Robert W. Baird Reiterates Regeneron Pharmaceuticals (REGN) At Neutral With $56 Price Target 10/14/2011 10:21:16 AM
  • Robert W. Baird Is Increasing Regeneron Pharmaceuticals (REGN) FY12 Estimate To -1.16 From -1.19 9/30/2011 8:11:28 AM
  • Robert W. Baird Reiterates Regeneron Pharmaceuticals (REGN) At Neutral With $56 Price Target 9/30/2011 8:10:34 AM
  • Robert W. Baird Is Cutting Regeneron Pharmaceuticals (REGN) FY12 Estimate To -1.91 From -1.04 8/18/2011 8:56:14 AM
  • Robert W. Baird Is Lowering Regeneron Pharmaceuticals (REGN) FY11 Estimate To -2.73 From -2.25 8/18/2011 8:55:44 AM
  • RBC Capital Markets Is Cutting Regeneron Pharmaceuticals (REGN) 2012 Rev. Estimate To 641.7 M From 647.8 M 7/29/2011 7:55:33 PM
  • RBC Capital Markets Is Lowering Regeneron Pharmaceuticals (REGN) 2011 Rev. Estimate To 480.1 M From 491.6 M 7/29/2011 7:55:27 PM
  • Robert W. Baird Reiterates Regeneron Pharmaceuticals (REGN) At Neutral With $56 Price Target 7/29/2011 9:52:53 AM
  • Robert W. Baird Is Cutting Regeneron Pharmaceuticals (REGN) FY 12 Estimate To -1.04 From -0.78 7/29/2011 9:52:28 AM
Copyright © 2026 RTTNews. All rights reserved. By using this site, you agree to the Terms of Service. About Us   |   Contact Us   |   Privacy   |   Sitemap